Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2008
11/13/2008US20080280883 Muscarinic Receptor Antagonists
11/13/2008US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers
11/13/2008US20080280868 Pyridine Derivatives and Their Use as Cb2 Receptor Modulators
11/13/2008CA2686387A1 1, 3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/12/2008EP1990337A1 Quinazoline derivatives,preparation methods and uses thereof
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1989199A1 Novel method for the preparation of stavudine polymorphic form i and form ii
11/12/2008EP1989188A1 Therapeutic piperazines as pde4 inhibitors
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
11/12/2008EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors
11/12/2008EP1641780B1 Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives
11/12/2008EP1346988B1 Process for preparing optically active 2,3-dihydro- benzofuran compounds
11/12/2008CN101304981A P2x7 receptor antagonists and methods of use
11/12/2008CN101304976A Inhibitors of viral replication
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432059C Quinazolinone derivatives useful as anti-hyperalgesic agents
11/12/2008CN100432056C Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449575 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection
11/11/2008US7449489 e.g. isopropyl [({2-[5-[2-(2-azabicyclo[2.2.2]oct-2-yl)- 1,1-dimethyl-2-oxoethyl]-2-(3,5-dimethylphenyl)-1H-indol-3-yl]propyl }amino)(3-pyridin-4-ylpyrrolidin-1-yl)methylene]carbamate; gonadotrophin releasing hormone antagonists; anticarcinogenic agent; breast, prostate, uretus cancer
11/11/2008US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc.
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449474 Tri-substituted ureas as cytokine inhibitors
11/11/2008US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/06/2008WO2008133900A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008133273A1 Pharmaceutical composition for treatment of alzheimer's disease
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols
11/06/2008WO2008131860A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008076046A8 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008WO2008072190A3 Compositions of azimilide dihydrochloride
11/06/2008WO2008072053A3 Substituted arylpyrazoles
11/06/2008WO2008020306A3 Isoindole derivatives
11/06/2008US20080275237 purification by esterification, amidation and crystallization; trans-Tetrahydrocannabinol 2-naphthoyl ester intermediates; stereospecific enantiomorphs; cost efficiency, simplification; don't need chromatographic or distillative separation; narcotic drugs
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/06/2008US20080275090 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/06/2008US20080275065 insecticide for representatives of the order Acarina; protection of plant propagation material from the attack by pests; N-(4-chloro-2-methyl-6-[([oxetan-2-ylmethyl]amino)carbonyl]phenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/06/2008US20080275022 Substituted Quinazolones as Anti-Cancer Agents
11/06/2008US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
11/06/2008US20080274891 Pyridine-3-ketone compound; plant growth controllers
11/06/2008US20080274107 Tyrosine kinase inhibitors
11/06/2008US20080274082 Oximyl hydroxyamic analogs as hepatitis c virus protease inhibitor
11/06/2008US20080274048 kit comprising an antioxidant such as ascorbic acid, p-aminobenzoic acid, cysteine, monothioglycerol, or gentisic acid covalently bound to a radiopharmaceutical ligand; optional targeting molecule
11/06/2008CA2682032A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/05/2008EP1988164A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor
11/05/2008EP1988090A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
11/05/2008EP1988087A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
11/05/2008EP1988082A1 Polynuclear complex and polymer thereof
11/05/2008EP1988080A1 Insecticidal substituted 2-aminoindanes
11/05/2008EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/05/2008EP1988076A1 Amide derivative or salt thereof
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987005A2 New pyridin-3-amine derivatives
11/05/2008EP1986747A2 Quinolones useful as inducible nitric oxide synthase inhibitors
11/05/2008EP1663970B1 Matrix metalloproteinase inhibitors
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1296973B1 Guanidine derivatives of quinazoline for use in the treatment of autoimmune diseases
11/05/2008EP1200424B1 C7 heterosubstituted acetate taxanes as antitumor agents
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101300248A Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections
11/05/2008CN101300246A Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
11/05/2008CN101300244A Novel cercosporamide derivative
11/05/2008CN101300235A Diaminopyrimidines as P2X3 and P2X2/3 modulators
11/05/2008CN100430400C Cyclic-aliphatic epoxy compound containing pheneylethylene cinnamyl or maleimide functional group
11/05/2008CN100430393C Pyran derivative
11/05/2008CN100430392C Carbamoyl-type benzofuran derivatives
11/05/2008CN100430391C Method for producing 2-[-5-(4-fluoprophenyl)-3-pyridylmethylaminomethyl]-chromane
11/05/2008CN100430390C Water-soluble triazole fungicide
11/05/2008CN100430389C Inhibition of phsphoinostide 3-dinase beta
11/05/2008CN100430379C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/05/2008CN100430378C New piperidine derivative
11/05/2008CN100430059C Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity
11/04/2008US7446201 Substituted heteroaryl benzofuran acids
11/04/2008US7446196 Leptomycin compounds
11/04/2008US7446195 High affinity thiophene-based and furan-based kinase ligands
11/04/2008US7446124 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
11/04/2008US7446117 Cox-2 inhibiting pyridine derivatives
11/04/2008US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
10/2008
10/30/2008WO2008130879A2 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008WO2008130853A1 Hydrazides and their use as metabotropic glutamate receptor potentiators - 681
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 694